Pengbo Jiang, MD
Urology · Orange, CANPI 1699185603
Payments from drug & device makers
What this record shows
This record is dominated by education: $8,000 of the $12,629 with a category attached, or 63.3%. Intuitive Surgical accounts for 86.4% of it on its own, with 3 other manufacturers making up the rest. Reporting peaked in 2023 at $9,195 and has fallen 89.9% since, to $933 in 2025.
Across 51 payments — averaging $247.63 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Intuitive Surgical$11K
- Boston Scientific$1K
- Calyxo, Inc.$335
- KARL Storz Endoscopy-america$202
What the payments were for
- Grants$1171%
- Travel & lodging$2,62421%
- Food & beverage$1,88815%
- Education$8,00063%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Intuitive Surgical | 30 | $10,917 |
| Boston Scientific | 15 | $1,175 |
| Calyxo, Inc. | 3 | $335 |
| KARL Storz Endoscopy-america | 3 | $202 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- DA VINCI SP$7,918
- Da Vinci Surgical System$2,617
- CVAC Aspiration System$240
- GENERAL ERECTILE DYSFUNCTION$117
- Flex-X$104
How this compares
$12,629 in reported general payments places this provider in the 80th percentile of 1,324 urology providers in California.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Potassium Citrate ErPotassium Citrate | 34 | $2,547 |
| Tamsulosin Hcl | 133 | $1,659 |
| Finasteride | 42 | $501 |
| Alfuzosin Hcl ErAlfuzosin Hcl | 16 | $420 |
| Nitrofurantoin Mono-MacroNitrofurantoin Monohyd/M-Cryst | 32 | $391 |
| Oxybutynin Chloride ErOxybutynin Chloride | 12 | $253 |
| Oxybutynin Chloride | 30 | $203 |
| Sulfamethoxazole-TrimethoprimSulfamethoxazole/Trimethoprim | 27 | $135 |
| Levofloxacin | 29 | $82 |
Paid to pharmacies, not to this prescriber.
Other urology in Orange
- Edward UchioOrange$849K
- Jaime LandmanOrange$657K
- Ralph ClaymanOrange$523K
- Faysal YafiOrange$335K
- Bela DenesOrange$235K
- Stephen FreedlandWest Hollywood$1.9M
- Arie BelldegrunLos Angeles$1.8M
- Mihir DesaiLos Angeles$1.5M
- Steven WilsonIndio$1.1M
- Stuart HoldenLos Angeles$1.1M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.